Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Venous Thromboembolism × Rivaroxaban × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 15 Plasma cell 2 Thoracic 1 Other hematologic neoplasm 1 Lymphoid 1 Genitourinary 1 CNS 1

Conditions

Venous Thromboembolism 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Thrombosis 1 Thromboembolism 1 Prostatic Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Inflammation 1 Immune System Diseases 1 Colonic Neoplasms 1 Cardiovascular Diseases 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Tinzaparin 1 Rivaroxaban 1 Gemcitabine 1 ALT-836 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05920343 2025-07-10

PREVENT-GU

Ottawa Hospital Research Institute

Phase 2/3 Recruiting

Classical hematologyGenitourinary

Urogenital Neoplasms, Urologic Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡